BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
154 results:

  • 1. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
    Prajapati KS; Kumar S
    Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.
    Wang D; Wang X; Zhang Y; Yu L; An J; Wang X; Huang Y; Han X
    Front Immunol; 2024; 15():1309509. PubMed ID: 38352877
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Yu Z; Deng P; Chen Y; Lin D; Liu S; Hong J; Guan P; Chen J; Zhong ME; Chen J; Chen X; Sun Y; Wang Y; Wang P; Cai Z; Chan JY; Huang Y; Xiao R; Guo Y; Zeng X; Wang W; Zou Y; Yu Q; Lan P; Teh BT; Wu X; Tan J
    Proc Natl Acad Sci U S A; 2024 Feb; 121(6):e2304619121. PubMed ID: 38289962
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inhibition of Autophagy Aggravates
    Tsai CH; Huang HC; Lin KJ; Liu JM; Chen GL; Yeh YH; Lu TL; Lin HW; Lu MT; Chu PC
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279345
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis.
    Wang X; Zhang H; Guo Z; Wang J; Lu C; Wang J; Jin R; Mo Z
    Aging (Albany NY); 2024 Jan; 16(1):348-366. PubMed ID: 38189879
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. First-line cdk4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis.
    Guo X; Zhou Y; Zhang K; Lu W; Zhong X; Wu S; Shen L; Chen H; Chen Y
    J Evid Based Med; 2024 Mar; 17(1):106-118. PubMed ID: 38102891
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
    Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
    BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combination of PARP inhibitor and cdk4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancer.
    Wang T; Liu W; Shen Q; Tao R; Li C; Shen Q; Lin Y; Huang Y; Yang L; Xie G; Bai J; Li R; Wang L; Tao K; Yin Y
    Cancer Sci; 2023 Nov; 114(11):4184-4201. PubMed ID: 37702298
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of BMI in Patients With Early Hormone Receptor-Positive Breast cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
    Pfeiler G; Hlauschek D; Mayer EL; Deutschmann C; Kacerovsky-Strobl S; Martin M; Meisel JL; Zdenkowski N; Loibl S; Balic M; Park H; Prat A; Isaacs C; Bajetta E; Balko JM; Bellet-Ezquerra M; Bliss J; Burstein H; Cardoso F; Fohler H; Foukakis T; Gelmon KA; Goetz M; Haddad TC; Iwata H; Jassem J; Lee SC; Linderholm B; Los M; Mamounas EP; Miller KD; Morris PG; Munzone E; Gal-Yam EN; Ring A; Shepherd L; Singer C; Thomssen C; Tseng LM; Valagussa P; Winer EP; Wolff AC; Zoppoli G; Machacek-Link J; Schurmans C; Huang X; Gauthier E; Fesl C; Dueck AC; DeMichele A; Gnant M;
    J Clin Oncol; 2023 Nov; 41(33):5118-5130. PubMed ID: 37556775
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. E3 ligase MG53 suppresses tumor growth by degrading cyclin D1.
    Fang M; Wu HK; Pei Y; Zhang Y; Gao X; He Y; Chen G; Lv F; Jiang P; Li Y; Li W; Jiang P; Wang L; Ji J; Hu X; Xiao RP
    Signal Transduct Target Ther; 2023 Jul; 8(1):263. PubMed ID: 37414783
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Two-team Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection Using Transanal Approach for Rectal cancer: A Retrospective Study.
    Shiraishi T; Ogawa H; Yamaguchi A; Shioi I; Shibasaki Y; Komine C; Ozawa N; Osone K; Okada T; Sano A; Sakai M; Sohda M; Shirabe K; Saeki H
    Anticancer Res; 2023 Jul; 43(7):3311-3319. PubMed ID: 37351984
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study.
    Selby LV; Clark EC; Liebner DA; Chen JL; Tinoco G; Bashian E; Beane JD; Pollock RE; Grignol VP
    Ann Surg Oncol; 2023 Nov; 30(12):7876-7881. PubMed ID: 37330448
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Managing a Long and Winding Road: Estrogen Receptor-Positive Breast cancer.
    Gnant M; Turner NC; Hernando C
    Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390922. PubMed ID: 37319380
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Endoscopic mucosal resection using cold snare versus hot snare in treatment for 10-19 mm non-pedunculated colorectal polyps: protocol of a non-inferiority randomised controlled study.
    Jiang Q; Yan X; Wang D; Zhang S; Zhang Y; Feng Y; Yang A; Wu D
    BMJ Open; 2023 May; 13(5):e070321. PubMed ID: 37217262
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. 5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon cancer Cells by Inhibiting STAT3.
    Yu Z; Chan S; Wang X; Sun R; Wang M; Wang Z; Zuo X; Chen J; Zhang H; Chen W
    Drug Des Devel Ther; 2023; 17():993-1006. PubMed ID: 37020802
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical outcomes and risk factors associated with poor prognosis after endoscopic resection of 10-20┬ámm rectal neuroendocrine tumors: a multicenter, retrospective study of 10-year experience.
    Goo JJ; Baek DH; Kim HW; Lee HS; Lee JY; Park SB; Song GA; Lee SH; Lee JH;
    Surg Endosc; 2023 Jul; 37(7):5196-5204. PubMed ID: 36947224
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast cancer.
    Muendlein A; Heinzle C; Brandtner EM; Leiherer A; Drexel H; Dechow T; Decker T
    Oncol Res Treat; 2023; 46(4):151-156. PubMed ID: 36750040
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Dieckol, a natural polyphenolic drug, inhibits the proliferation and migration of colon cancer cells by inhibiting PI3K, AKT, and mTOR phosphorylation.
    Dai W; Dai YG; Ren DF; Zhu DW
    J Biochem Mol Toxicol; 2023 May; 37(5):e23313. PubMed ID: 36683349
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High therapeutic efficacy of 5-Fluorouracil-loaded exosomes against colon cancer cells.
    Shekh R; Ahmad A; Tiwari RK; Saeed M; Shukla R; Al-Thubiani WS; Ansari IA; Ashfaque M; Bajpai P
    Chem Biol Drug Des; 2023 Apr; 101(4):962-976. PubMed ID: 36651797
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway.
    Peng BY; Singh AK; Chan CH; Deng YH; Li PY; Su CW; Wu CY; Deng WP
    BMC Cancer; 2023 Jan; 23(1):1. PubMed ID: 36597025
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.